Mostly Luxottica

Two American sunglass brands, a French-listed owner registered in a Paris suburb, and the president of LensCrafters, on camera, unable to say how many of the frames on his own shelves were made by somebody else.

---

이 글의 한국어판 → 간판은 여섯인데 고용주는 하나다

The shelf’s six questions, asked of Ray-Ban and Oakley. Two brands born in the United States, and every box after the first one lands somewhere else — while the sixth stays empty on purpose.

"I would guess, mostly Luxottica. Yuh."

On October 7, 2012, CBS broadcast a 60 Minutes segment called "Sticker Shock." Lesley Stahl reported it and Shachar Bar-On produced it, and somewhere in the middle Stahl is standing inside a LensCrafters store with Mark Weikel, then the president of the chain, asking him a question that should have taken four seconds.

"How many non-Luxottica brands do you sell here?"

"We probably have a few brands that aren't Luxottica."

"Mostly Luxottica?"

"I would guess, mostly Luxottica. Yuh."

She kept going. Since Luxottica owns you, she asked, does a customer get a break on the frames Luxottica makes? Weikel began describing a variety of services and a broad assortment of frames. "Mark, you're not answering my question," Stahl said. "I'm asking if you charge less for frames made by Luxottica since you're the same company." He answered that every retail optical brand decides its own pricing. The narration cut in: That's a no. Consumers do not get a break.

The chief executive was better at it. Andrea Guerra ran Luxottica then, and when Stahl put the structural objection to him — it is an illusion of choice if you are all owned by the same company — he neither flinched nor conceded. "I think this is totally wrong," he said. "The question is, what kind of choice consumer has. It's not a question of how many you own."

Borrow that yardstick and hold onto it, because it is his and not mine. Not how many brands one company owns. What kind of choice consumer has. Everything below is an attempt to answer Guerra's question with Guerra's own materials, and it takes a while, because the company he was defending in 2012 has since been folded into a larger one that files its accounts in France.

Six questions

This magazine asks six questions of everything on an American shelf. Where was it born. Where is it incorporated. Where is the head office. Who owns the shares. Where is it made. Who signs the paycheck. When the six answers cluster, there is nothing to write. When they scatter, the gap is the article.

Ray-Ban and Oakley scatter across five countries, and not one of the five is the country the brands are from.

Born: Ray-Ban in Rochester, New York, in 1937, inside the optical company Bausch & Lomb. Oakley in southern California, where, by its own account to regulators, it "commenced operations in 1977." Incorporated: EssilorLuxottica S.A., a French company carrying the registration number SIREN 712 049 618. Head office: Charenton-le-Pont, a commune on the southeastern edge of Paris, though every set of results goes out datelined simply "Paris, France." Shareholders: Delfin S.à r.l., a Luxembourg holding company owned by the Del Vecchio family, sitting on about 32 percent of a company whose own bylaws cap any single shareholder's votes at 31. Factories: Italy, China, India, Brazil, and one plant in California. Paycheck: more than 200,000 people in 150 countries, of whom the number working in the United States has never been published.

That last one is not an oversight. It is the pattern of the whole file.

Rochester in 1937, and a date the company will not confirm

Ask EssilorLuxottica when Ray-Ban was born and you get a year and nothing else. Its 2024 registration document lists the group's brands like a family tree with birthdates attached: Essilor (1849), Salmoiraghi & Viganò (1865), Persol (1917), Ray-Ban (1937), Luxottica (1961). Luxottica's 2007 annual report to the Securities and Exchange Commission says the same thing in a sentence: "Ray-Ban: Created in 1937 and acquired by us in 1999."

Everything else you have read about that year comes from somewhere else. The 1936 prototype, the patent said to have issued on May 7, 1937, the Army Air Corps officer who is supposed to have asked for it, the frame weighed in grams — none of it appears in a company document I could open. I am not saying those things are false. I am saying the company that owns the brand has declined, for ninety years, to put them in writing, and that a series about where objects come from should notice when a birth certificate has only a year on it.

Oakley is the opposite problem. There the company put a date in writing, and the date most people repeat is a different one. The first sentence of Oakley's last annual report as a public company, filed on March 9, 2007, reads: "Oakley, Inc., a Washington corporation, was formed in March 1994 to succeed to the assets and liabilities of Oakley, Inc., a California corporation, which commenced operations in 1977 and began to sell sunglasses in 1984."

Three things fall out of one sentence. Operations began in 1977, not 1975, and the gap is two years wide. Sunglasses did not arrive until 1984, seven years after the company started, which means the sunglass brand spent its first seven years selling something else. And the corporation that went public was chartered in Washington State in 1994, not in the California town where the thing was actually built.

By 2006 the company was doing $761.9 million in net sales, holding 579 patents and 1,176 trademarks, assembling its eyewear in about 550,000 square feet at Foothill Ranch and running a second plant of 63,000 square feet in Nevada for its X Metal frames. It also owned a retail chain called Sunglass Icon, which its own filing described as "the second largest sunglass specialty retail chain in the United States." Hold onto that detail. The largest one belonged to the company that was about to buy it.

The contribution, not the takeover

The sentence you will read most often about 2018 is that a French company bought an Italian one. That is not what happened, and the correct version is stranger.

Luxottica's own filing for 2016 sets out the mechanics. On January 15, 2017, Delfin — Leonardo Del Vecchio's Luxembourg holding company, and Luxottica's controlling shareholder — agreed to contribute its entire stake in Luxottica to Essilor. Not sell. Contribute. In exchange Delfin took newly issued Essilor shares, and Essilor, once the contribution completed, would change its name to EssilorLuxottica and offer to buy the rest of Luxottica.

So the listed company that survived was the French one, descended from an 1849 Paris workers' cooperative of spectacle-makers called the Association Fraternelle des Ouvriers Lunetiers. Luxottica Group S.p.A. became its subsidiary. And because the price was paid in stock rather than cash, the Italian family that had just handed over its Italian company came out the other side as the largest shareholder of the French one. Control did not move to Paris. It moved into Paris, and stayed Italian.

The American exit had happened earlier and quietly. Luxottica's shares traded in New York from 1990 to 2017 under the ticker LUX. Trading there fell to 3.7 percent of the world's daily average volume in the stock, and the company delisted. An American who wants to own a piece of Ray-Ban today has to buy in Paris.

Which leaves an odd residue on the American website. Scroll to the bottom of ray-ban.com and the copyright line reads "Copyright ©2026 Luxottica Group S.p.A. — All Rights Reserved," naming the Italian subsidiary rather than the French parent, on a page selling a brand invented in New York State.

Lenses, frames, its own brands, other people’s brands, six store banners and an insurer, inside one company. The banners come from a federal court’s defendant list; the structure comes from the company’s own filing in Paris.

One employer, six signs

Here is the sentence this piece exists for, and it comes from a federal court file rather than from an investigative reporter.

When two groups of American plaintiffs sued in the Southern District of New York, they had to name the defendants, and Judge Mary Kay Vyskocil's opinion lists them. Number three on the list is "Luxottica of America Inc., which… does business as LensCrafters, Pearle Vision, Target Optical, Sunglass Hut, Oakley retail stores, and Ray-Ban retail stores."

Six signs. One employer. A shopper can walk a mall concourse, get an eye exam under one banner, look at Ray-Bans under a second, price a competing pair under a third, and buy under a fourth, and the name printed on the pay stub of every person she spoke to may not change once. The banners are the choice. The payroll is the fact.

Two more entities on the same defendant list finish the picture. EyeMed Vision Care, LLC, based in Cincinnati, Ohio, sells vision insurance. Vision Source, LLC is a group of independent optometric practices, which the plaintiffs put at around three thousand locations. So the insurer that decides which providers are in network, the stores that are in it, the frames on their shelves and the lenses that go into the frames can all report upward to the same French registration number.

The company says so itself

This is the part where a piece like this normally reveals something. There is nothing to reveal. EssilorLuxottica publishes the structure, under a heading, in the document it files with the French market regulator.

"At the heart of the Group's success lies its vertical integration, a cornerstone of Essilor and Luxottica's business model from the very beginning," the 2024 registration document says. "Over time, vertical integration expanded beyond manufacturing to encompass distribution, starting with the wholesale channel and later the retail channel."

The strategy is older than the merger by forty-four years. In 1974 Del Vecchio bought Scarrone S.p.A., an Italian distributor, and that purchase is the one the company itself marks as the beginning. Avant-Garde Optics, an American wholesaler, followed in 1981. In 1988 came the first fashion licence, with Giorgio Armani, and after it Chanel in 1999, Prada and Versace in 2003, Dolce & Gabbana and Burberry in 2006, Ralph Lauren in 2007, Tiffany in 2008, Coach in 2012, Michael Kors in 2015, Jimmy Choo and Moncler in 2023, Diesel in 2024. Then retail: LensCrafters in 1995, Sunglass Hut in 2001, OPSM in 2003, Cole National in 2004, GrandVision in 2021.

The online layer is the one shoppers do not see, because it does not look like a layer. The footer of ray-ban.com carries a heading, "Discover other brands from Luxottica," and under it a list: Oakley, Persol, Oliver Peoples, Vogue Eyewear, Sunglass Hut, LensCrafters, Target Optical, Glasses.com, ContactsDirect, Pearle Vision, FramesDirect, EyeBuyDirect.com, Costa del Mar, Nuance Audio. A customer who leaves the expensive brand site looking for cheap glasses online and lands on EyeBuyDirect has not left. A customer hunting a discount frame at FramesDirect has not left. A customer comparing contact lens prices at ContactsDirect has not left.

And EyeMed, on its own site, states the outcome without embarrassment: "It's no wonder that nearly 98% of our members stay in-network." That network, the company is careful to say, includes independent optometrists as well as LensCrafters, Pearle Vision and Target Optical. The 98 percent is a network figure, not a house figure, and anyone who quotes it as proof of steering is quoting past the evidence.

So return to Guerra's yardstick. What kind of choice does the consumer have? The honest answer is that the consumer has an enormous amount of choice at every level except the one that sets the price, and that this is not an accusation but a description the company would sign.

In 2018 Brussels and Washington cleared the merger on the same day, without conditions. Four years earlier Seoul had blocked a different Essilor purchase, on the lens shares below. Same company, different deals, different answers.

What the regulators said, and what the judge said

Brussels and Washington answered the same question on the same day, and both answered no.

On March 1, 2018, the European Commission cleared the Essilor–Luxottica combination unconditionally in Case M.8394, after a Phase II investigation that had spent its time on exactly the fear this article is about: whether a merged firm could use Luxottica's frames as a lever to make opticians buy Essilor lenses, or shut rival lens makers out. The conclusion was that "the merger would not adversely affect competition in the European Economic Area or any substantial part of it."

The same day, the Federal Trade Commission's commissioners voted two to nothing to close their own investigation, File No. 171-0060. The statement they signed is worth reading in full because of the way it hedges its own conclusion. Staff, it says, "extensively investigated every plausible theory and used aggressive assumptions to assess the likelihood of competitive harm." Then: "Assessing the likely competitive effects of a proposed transaction is a fact-specific exercise that takes into account the current market dynamics, which may be different in the future. Here, however, the evidence did not support a conclusion that Essilor's proposed acquisition of Luxottica may be substantially to lessen competition."

Which may be different in the future is not an acquittal. It is a receipt with a date on it.

Six years later American buyers tried the argument in court and lost it on a technicality that is more interesting than the argument. In In re Eyewear Antitrust Litigation, direct purchasers and indirect purchasers each filed their own amended complaint alleging that EssilorLuxottica had assembled a "premium eyewear" monopoly out of brand acquisitions, exclusive fashion licences, retail chains, insurers, laboratories and an optometrist group. Their share numbers — 80 percent of American premium eyewear retail sales in 2022, sourced to a website called Statista, and at least 52 percent of custom lens retail sales in 2023 — were allegations, never findings, and the judge never reached them.

She threw out the market instead. Her reasoning is the strongest version of the case against everything above, so here it is at its strongest.

The plaintiffs defined a "premium eyewear market" that they filled with EssilorLuxottica's own brands and licences, and from which they excluded Warby Parker, a company they themselves described in their own pleadings as well known, popular, one of the nine largest brick-and-mortar eyewear retailers and the third-largest online eyewear retailer in the country. "A '$195' pair of sunglasses 'is in the market' if 'it's Ralph Lauren,'" Judge Vyskocil wrote. "However, a similar '$195' pair of sunglasses 'is outside of the market' if it is manufactured and sold by Warby Parker." The only justification offered for the exclusion was that a Kering executive had once dismissed Warby Parker as having little to do with luxury. At oral argument, counsel for the indirect purchasers conceded that Warby Parker's prices overlap with premium ones. On the lens side, the alleged 52 percent was, in her phrase, "a bare majority," insufficient by itself to infer monopoly power. As for barriers to entry, the plaintiffs had defeated themselves in their own document: they alleged that Warby Parker recently built a $16 million optical lab in New York. And they conceded elsewhere that the defendants compete with Kering.

That is a serious opinion and the correct response to it is not a shrug. If a $195 pair from an independent company is genuinely interchangeable with a $195 pair from a licensed fashion house, then the aisle contains competition after all, and the thing this article keeps calling a structure is just a large firm in a market with entrants in it. The judge dismissed both complaints on September 26, 2025, with leave to replead by October 17 and a warning that it was the plaintiffs' final opportunity. She also noted, in a sentence with real irritation in it, that the plaintiffs had engaged in "procedural antics" bordering on forum shopping and that "astonishingly… the different plaintiffs cannot agree on the market or markets that the mix of entities they call EssilorLuxottica allegedly dominates."

What happened after October 17, 2025, I could not establish from primary sources. Whether a second amended complaint was filed, whether it survived, whether anyone appealed: unknown, and I am not going to guess at the end of a paragraph like that one.

Two things are settled, though, and they should not be blurred together. No American court has found this company to be a monopoly. No American court has found that it is not one. What was decided is that these plaintiffs drew the wrong stage.

Twenty-nine dollars, and a year in the warehouse

Now the part where the yardstick gets tested on a single object.

On April 28, 1999, Bausch & Lomb and Luxottica announced that Bausch & Lomb would sell its entire sunglass business — Ray-Ban, Revo, Arnette and Killer Loop — for a cash purchase price of $640 million. Read the seller's explanation and the size of the mistake becomes visible. William M. Carpenter, then Bausch & Lomb's chairman and chief executive, said the sale would let his company "continue to refine our focus on our strategic objective of becoming the world's preeminent technology-based healthcare company for the eye," and in the same breath he named the other non-core businesses he wanted gone by year end: Miracle Ear hearing aids, and the Charles River Laboratories subsidiary.

In 1999, at the company that had invented it, Ray-Ban was an item on a disposal list, between a hearing-aid brand and a laboratory-animal business.

Del Vecchio, in the same release, said what he was actually buying. "With this we add the most prestigious sun brands in the world to our portfolio," he said. "We gain access to very cost efficient, high quality sunglass lens and lens coating production." Brands and lens production, in one sentence, from the man whose strategy since 1974 had been to own every step.

Then he did something a public company rarely does with a newly acquired revenue line. He stopped selling it.

"We stopped selling sunglasses from Ray-Ban for more or less a year," Guerra told Stahl in 2012. She started to say that the glasses had cost almost nothing when Luxottica bought them, and he supplied the figure himself. "Twenty-nine dollars." At the drug store, at a gas station, Stahl said, and you took them off the market. "We refurbished everything," Guerra said. The narration finished the thought: those $29 pairs, it said, could now cost $150 and more, and Ray-Ban had become the world's best-selling sunglass brand. That is a multiple of more than five, my division, worked from a broadcast figure rather than a company one.

The pattern repeated in 2007, with a company that had tried not to sell. Stahl put it to Guerra bluntly. "You bought Oakley. They tried to compete and they lost and then you bought them." Guerra would not take the sentence. "I understand your theory, but they understood that life was better together." The filings are less poetic and more exact: a merger agreement signed on June 20, 2007; the Federal Trade Commission granting early termination of the antitrust waiting period on August 24 without a second request for information; closing on November 14 at $29.30 a share, for a total of approximately $2.1 billion, financed by two credit facilities arranged the previous month. Not a hostile tender offer. A negotiated deal a shareholder meeting approved.

Add the two purchase prices and you get $2.74 billion for the two best-known premium sunglass brands in the world. It is a nominal sum across eight years, unadjusted for inflation or currency, and I offer it as a shape rather than a valuation.

Forty-one percent

Everyone says Italian. The last time this company disclosed where its glasses were actually made, the number was 41.

Luxottica's 2016 filing — its last detailed one before the New York delisting — put total output at about 93 million frames and sunglasses and split the production four ways. Six facilities in Italy, five of them in the northeast and one near Turin, made 41 percent. Three plants in China plus a small one in India made another 46 percent. Foothill Ranch in California, which assembles most of Oakley's eyewear, made 10 percent. Campinas in Brazil made the last 3.

Subtract and 59 percent of the output of the world's most Italian eyewear company came from outside Italy, which is my arithmetic on the company's four numbers. Divide the 93 million by the days in a year and the group was finishing about 255,000 pairs a day, also mine. The Dongguan logistics hub alone, opened in 2006, moves an average of 200,000 units daily by the company's own count.

The Chinese plants were not built as Chinese plants. From 1997 to 2001 Luxottica ran Dongguan inside Tristar Optical Company Ltd., a fifty-fifty joint venture with a Japanese partner, bought out the other half in 2001, and put up a new factory in 2006. Nine years after that, output had gone from 41.8 million units in 2007 to 93 million in 2016, a multiple of 2.2, my division again.

Since 2018 the group has not published that split at all. What it publishes now is a boilerplate line: over 200,000 employees, 150 countries, 600 operations facilities, 300,000 eye care professionals served, 18,000 stores. Nothing in it tells you where a frame is poured.

One number in the 2025 results tells you sideways. Reporting on February 11, 2026, Francesco Milleri and Paul du Saillant put adjusted gross margin down 260 basis points on the year and listed "the US import tariff headwind" first among the reasons. A company whose American sales are made in America does not lose margin to an American import tariff. The tariff line is a production disclosure in disguise.

The paycheck box, mostly empty

Of the six questions, this is the one the company answers least.

It will tell you that it employs more than 200,000 people across 150 countries. It will tell you that 97,000 employees in 85 countries hold shares, up from 83,500 the year before — at most 48.5 percent of the workforce, my division, and a ceiling rather than a rate, because "more than 200,000" has no top. It will tell you that around 35,000 people belong to Valoptec, the association of current and former employee shareholders. Those numbers are not decoration. Essilor's ancestor was a workers' cooperative, and the company says so plainly: that 1849 structure, which "involved employees in corporate governance, is at the heart of a strong employee shareholding culture that remains central to EssilorLuxottica today."

Now ask a narrower question. How many of those people work in the United States?

The 2025 results give revenue by region to the million euro: North America 12,787, EMEA 10,779, Asia-Pacific 3,410, Latin America 1,515, on 28,491 total. North America is 44.9 percent of group revenue, my division. The same release gives directly operated stores by region, 3,814 of them in North America, out of 13,684 direct and 4,066 franchised worldwide. Money is regional. Stores are regional. People are global, and only global.

So the largest single market for a French-listed group, the market that supplies nearly half its revenue and both of the brands under discussion, has no published headcount at all. That is not a scandal. It is a choice about what to measure, and it is the reason the sixth box in this series is so often the emptiest one.

Eight pieces

Leonardo Del Vecchio died on June 27, 2022, and his will divided Delfin equally: eight heirs, 12.5 percent each. An empire built by an orphan from Agordo, cut into eighths in a single document.

In the spring of 2026 one of the eight tried to reassemble it. Leonardo Maria Del Vecchio, then thirty-one, moved to buy out his brother Luca and his sister Paola and take his own share from 12.5 percent to 37.5, a transaction reported at around ten billion euros. He posted a line on Instagram: "An inheritance is coming, responsibilities must be assumed." Other heirs objected. The Delfin board held back. The deal did not happen.

On August 25, 2026, he announced he was leaving every position he held, effective the 31st. He had been the group's chief strategy officer. He had also been chairman of Ray-Ban. A spokesperson said he was going "to devote himself to new entrepreneurial projects." In a letter to Milleri published by Milano Finanza, he described the company's management style as "remote" and "impersonal." He remains a 12.5 percent owner of Delfin, which is the whole point: he could resign the jobs and could not resign the stake.

Set that against the mechanism in the bylaws. Delfin holds about 32 percent of EssilorLuxottica, a figure whose exact decimal I take from a news agency rather than a filing, and article 23 caps the votes of any shareholder at 31 percent. Roughly one percentage point of the family's holding does not vote. That is the smallest and most precise thing in this article, and it says more about how the company is built than any share-of-market estimate in the litigation.

From the Army Air Corps to Meta

Ray-Ban Meta went on sale in September 2023, and the company now calls it the number one selling AI glasses in the world. Oakley Meta followed on June 20, 2025, announced as a new category of "Performance AI glasses." In the 2025 results the two lines together are given at more than seven million units sold in the year, and in the same document the company notes that AI glasses pulled gross margin down, because the category earns less per unit than the eyewear beside it.

Reporting in December 2025, based on a remark by a member of the board, put Meta's stake in EssilorLuxottica at 3 percent or more, worth roughly three billion euros. That figure comes from the press and not from a company filing or a regulatory notification, and I could not find the underlying disclosure, so treat the number as reported rather than confirmed. What is confirmed is the direction. Meta did not ask for a board seat.

Whatever the shareholding turns out to be, the object has changed. A brand created in 1937 for the eyes of American military pilots now ships with a camera and microphones in the hinges, and its most important commercial partner is an advertising company in Menlo Park.

What kind of choice

Add up what is known. Two American brands, one born in New York State and one in southern California. A French parent registered in a Paris suburb, run from Paris, engineered in Agordo and Dongguan. A Luxembourg family holding company as the largest shareholder, its votes clipped by one point. Manufacturing that was 59 percent non-Italian the last time anyone counted in public, in 2016. An American subsidiary that operates six retail banners and hands out one set of pay stubs. An insurer in Cincinnati whose members stay in network 98 percent of the time.

Now add up what is not known, because that list is the honest half of this article. The current split of production by country: not published since 2016. The number of employees in the United States: not published at all. The size of Meta's holding: reported, not filed. The state of the antitrust docket after October 17, 2025: unresolved in every source I could open. The markup on a pair of sunglasses: refused. In 2012 the 60 Minutes narration said such glasses can sell for up to twenty times what they cost to make, and the sentence immediately before it said that Luxottica would not disclose its markup. Those two sentences belong together and are usually quoted apart.

Stahl, near the end, asked Guerra how consumers benefit when prices stay high. He answered by comparing the business to a shoe company, and she pushed once more, and he gave her the line that has outlived the segment.

"Everything is worth what people are ready to pay."

It is a complete answer to a question about price and no answer at all to the one he asked himself earlier, about what kind of choice the consumer has. Mark Weikel, standing in his own store with a reporter, was closer to it. He was not being evasive so much as accurate. He genuinely did not know how many of the brands around him were somebody else's, because in that aisle there is no working difference between knowing and not knowing.

Mostly Luxottica. Yuh.